HomeCTNM • NASDAQ
add
Contineum Therapeutics Inc
Previous close
$12.11
Day range
$12.07 - $13.09
Year range
$3.35 - $16.31
Market cap
455.87M USD
Avg Volume
248.50K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 17.12M | 0.40% |
Net income | -15.16M | -4.06% |
Net profit margin | — | — |
Earnings per share | -0.49 | 12.50% |
EBITDA | -17.03M | -0.34% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 262.90M | 28.39% |
Total assets | 276.64M | 29.97% |
Total liabilities | 15.65M | 5.90% |
Total equity | 260.99M | — |
Shares outstanding | 37.34M | — |
Price to book | 1.73 | — |
Return on assets | -18.31% | — |
Return on capital | -18.80% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -15.16M | -4.06% |
Cash from operations | -13.04M | -27.84% |
Cash from investing | -47.45M | -405.46% |
Cash from financing | 93.46M | 14,458.41% |
Net change in cash | 32.97M | 274.00% |
Free cash flow | -8.15M | -46.56% |
About
Founded
2009
Website
Employees
51
